SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Celltech Group (NYSE: CLL) -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (50)10/18/2002 10:38:24 AM
From: keokalani'nui  Read Replies (1) | Respond to of 123
 
Inhale's PEG technology has been used in these drug candidates from inception

Did any shareholders know this? I don't recall Celltech ever claiming anything but proprietary ownership of its peg-fragment technology. I wonder if x870 is not mentioned because it is already licensed.



To: nigel bates who wrote (50)10/18/2002 5:22:07 PM
From: keokalani'nui  Read Replies (1) | Respond to of 123
 
Nigel, did you listen to or read anything about the R&D day, especially anything about the PDE4 in mrk's hands? Two candidates blah blah, something I couldn't figure out???? Something set off an alarm. This is an important program (to me).


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News